CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $3.4B, above the global median of $1.15B
- FinancialsAltman Z-Score 3.58: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
22.87BCNY3.40B · vs all stocks (USD)
Trailing P/E
76.00xRevenue (TTM)
15.96BCNY2.37B · vs all stocks (USD)
Profit Margin
1.94%Beta
-0.0660xvs all stocks
52-Week Change
124.75%vs all stocks
Market Capitalization
22.87BCNY3.40B · vs all stocks (USD)
Enterprise Value
21.78BCNY3.24B · vs all stocks (USD)
Trailing P/E
76.00xForward P/E
30.40xPEG Ratio
-3.04xPrice to Sales (TTM)
1.44xPrice to Book (MRQ)
3.92xEnterprise to Revenue
1.36xEnterprise to EBITDA
30.03xGross Margin
24.11%Profit Margin
1.94%Operating Margin
5.27%Return on Assets (TTM)
2.24%Return on Equity (TTM)
5.27%Revenue (TTM)
15.96BCNY2.37B · vs all stocks (USD)
Revenue per Share (TTM)
6.17CNYUpdated Aug 20, 2026Quarterly Revenue Growth
5.89%Gross Profit (TTM)
4.01BCNY596.02M · vs all stocks (USD)
EBITDA (TTM)
1.03BCNY152.77M · vs all stocks (USD)
Net Income (TTM)
309.80MCNY46.07M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-24.30%Operating Cash Flow (TTM)
718.17MCNY106.80M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
632.81MCNY94.10M · vs all stocks (USD)
5-Year Average Dividend Yield
0.98%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
774.00MCNYFY2025 · Dec 31, 2025Revenue
15.96BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
11.82BCNYFY2025 · Dec 31, 2025Gross Profit
4.15BCNYFY2025 · Dec 31, 2025Operating Income
730.51MCNY108.63M · vs all stocks (USD)
Pre-tax Income
572.74MCNYFY2025 · Dec 31, 2025Income Tax Expense
173.96MCNYFY2025 · Dec 31, 2025Net Income
398.78MCNYFY2025 · Dec 31, 2025EBIT
615.29MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.03BCNYFY2025 · Dec 31, 2025Research & Development
145.01MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.96BCNYFY2025 · Dec 31, 2025Other Operating Expenses
124.64MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
24.35MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
42.55MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1400CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
2.58BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
2.58BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
398.78MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-37.18MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
472.75MCNYFY2025 · Dec 31, 2025Free Cash Flow
329.36MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
3.36BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
398.78MCNYFY2025 · Dec 31, 2025Other Non-cash Items
49.84MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
224.21MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-200.08MCNYFY2025 · Dec 31, 2025Capital Expenditures
-143.38MCNYFY2025 · Dec 31, 2025Sale of Investments
293.03KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-143.09MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.35BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.70BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-33.29MCNYFY2025 · Dec 31, 2025Other Financing Charges
-71.67MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-457.19MCNYFY2025 · Dec 31, 2025Shares Outstanding
2.52BSharesUpdated Aug 20, 2026Float Shares
1.31BSharesUpdated Aug 20, 2026% Held by Insiders
52.25%vs all stocks
% Held by Institutions
0.61%vs all stocks
Total Cash (MRQ)
3.18BCNY473.20M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.26CNYUpdated Aug 20, 2026Total Debt (MRQ)
1.22BCNY181.42M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1838xCurrent Ratio (MRQ)
1.45xBook Value per Share (MRQ)
2.33CNYUpdated Aug 20, 2026Total Assets
14.29BCNY2.12B · vs all stocks (USD)
Total Current Assets
10.65BCNYFY2025 · Dec 31, 2025Total Liabilities
7.83BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.63BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
402.98MCNYFY2025 · Dec 31, 2025Total Current Liabilities
7.42BCNYFY2025 · Dec 31, 2025Cash
3.34BCNYFY2025 · Dec 31, 2025Cash Equivalents
96.07MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.44BCNYFY2025 · Dec 31, 2025Accounts Receivable
4.39BCNYFY2025 · Dec 31, 2025Inventory
2.06BCNYFY2025 · Dec 31, 2025Accounts Payable
4.03BCNYFY2025 · Dec 31, 2025Short-term Debt
1.18BCNYFY2025 · Dec 31, 2025Other Current Liabilities
85.25MCNYFY2025 · Dec 31, 2025Long-term Debt
61.64MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
997.76KCNYFY2025 · Dec 31, 2025Common Stock (Book)
2.52BCNYFY2025 · Dec 31, 2025Retained Earnings
2.99BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
6.46BCNY960.98M · vs all stocks (USD)
52-Week Low
2.84CNYUpdated Aug 20, 202652-Week High
9.27CNYUpdated Aug 20, 202652-Week Change
124.75%vs all stocks
Beta
-0.0660xvs all stocks
50-Day MA
4.75CNYUpdated Aug 20, 2026200-Day MA
3.88CNYUpdated Aug 20, 2026Avg 10-Day Volume
420.18MSharesUpdated Aug 20, 2026Avg 30-Day Volume
420.53MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.1200CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
High Machinery Share, High Accumulated Depreciation Share, And Elevated Sales-To-Non-Current-Assets
Machines are most of what it owns, mostly written off, and still producing plenty of sales.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.58: safe zoneNotable
Altman Z-Score: 3.58
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $3.4B, above the global median of $1.15BNotable
Market cap (USD): 3,400,710,641.221Global Median: 1,146,734,693.424
Revenue is $2.37B, above the global median of $520.53MNotable
Revenue (USD): 2,374,127,387.628Global Median: 520,528,949.311
Levered free cash flow is $94.1M, above the global median of $16.24MNotable
Levered free cash flow (USD): 94,104,763.471Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Tasly Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Nhwa Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hubei Jumpcan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Arcus Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Lepu Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Ideaya Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Alumis Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Hanmi Pharm Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Pegbio Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule